Airway mucus and asthma: The role of MUC5AC and MUC5B

Journal of Clinical Medicine

Volumn 6, Issue 12, 2017, Pages

  Bonser, Luke R ^a   Erle, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; MUC5AC; MUC5B

Indexed keywords

ACETYLCYSTEINE; CORTICOSTEROID; DUPILUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; INTERLEUKIN 13; INTERLEUKIN 23; LEBRIKIZUMAB; MUCIN; MUCIN 19; MUCIN 2; MUCIN 5AC; MUCIN 5B; NOTCH2 RECEPTOR; OMALIZUMAB; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCUS; CELL MIGRATION; CYTOKINE PRODUCTION; DEFENSIVE BEHAVIOR; DISEASE SEVERITY; GENE EXPRESSION; GLYCOSYLATION; HOMEOSTASIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG INJURY; METAPLASIA; MUCOCILIARY CLEARANCE; NONHUMAN; PROTEIN MULTIMERIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SUFFOCATION; UPREGULATION;

EID: 85114280291     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm6120112     Document Type: Review

References (129)

1. Masoli, M.; Fabian, D.; Holt, S.; Beasley, R. Global Initiative for Asthma (GINA) Program The global burden of asthma: Executive summary of the GINA Dissemination Committee Report. Allergy 2004, 59, 469-478, doi:10.1111/j.1398-9995.2004.00526.x.
2. Pearce, N.; Aït-Khaled, N.; Beasley, R.; Mallol, J.; Keil, U.; Mitchell, E.; Robertson, C. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007, 62, 758-766, doi:10.1136/thx.2006.070169.
3. Fuhlbrigge, A.L.; Adams, R.J.; Guilbert, T.W.; Grant, E.; Lozano, P.; Janson, S.L.; Martinez, F.; Weiss, K.B.; Weiss, S.T. The Burden of Asthma in the United States. Am. J. Respir. Crit. Care Med. 2002, 166, 1044-1049, doi:10.1164/rccm.2107057.
4. Ferkol, T.; Schraufnagel, D. The Global Burden of Respiratory Disease. Ann. Am. Thorac. Soc. 2014, 11, 404-406, doi:10.1513/AnnalsATS.201311-405PS.
5. Fanta, C. H.; Asthma, N. Engl. J. Med. 2009, 360, 1002-1014, doi:10.1056/NEJMra0804579.
6. Jeffery, P.K.; Li, D. Airway mucosa: Secretory cells, mucus and mucin genes. Eur. Respir. J. 1997, 10, 1655-1662.
7. Fahy, J.V.; Dickey, B.F. Airway Mucus Function and Dysfunction. N. Engl. J. Med. 2010, 363, 2233-2247, doi:10.1056/NEJMra0910061.
8. Hackett, N.R.; Shaykhiev, R.; Walters, M.S.; Wang, R.; Zwick, R.K.; Ferris, B.; Witover, B.; Salit, J.; Crystal, R.G. The human airway epithelial basal cell transcriptome. PLoS ONE 2011, 6, e18378, doi:10.1371/journal.pone.0018378.
9. Thornton, D.J.; Sheehan, J.K. From mucins to mucus: Toward a more coherent understanding of this essential barrier. Proc. Am. Thorac. Soc. 2004, 1, 54-61, doi:10.1513/pats.2306016.
10. Erle, D.J.; Sheppard, D. The cell biology of asthma. J. Cell Biol. 2014, 205, 621-631, doi:10.1083/jcb.201401050.
11. Button, B.; Cai, L.-H.; Ehre, C.; Kesimer, M.; Hill, D.B.; Sheehan, J.K.; Boucher, R.C.; Rubinstein, M. A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia. Science 2012, 337, 937-941, doi:10.1126/science.1223012.
12. Kim, W.D. Lung mucus: A clinician’s view. Eur. Respir. J. 1997, 10, 1914-1917.
13. Dunnill, M.S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 1960, 13, 27-33.
14. Messer, J.W.; Peters, G.A.; Bennett, W.A. Causes of Death and Pathologic Findings in 304 Cases of Bronchial Asthma. Dis. Chest 1960, 38, 616-624, doi:10.1378/chest.38.6.616.
15. Kuyper, L.M.; Paré, P.D.; Hogg, J.C.; Lambert, R.K.; Ionescu, D.; Woods, R.; Bai, T.R. Characterization of airway plugging in fatal asthma. Am. J. Med. 2003, 115, 6-11, doi:10.1016/00029S-S343(03)00241-9.
16. Evans, C.M.; Kim, K.; Tuvim, M.J.; Dickey, B.F. Mucus hypersecretion in asthma: Causes and effects. Curr. Opin. Pulm. Med. 2009, 15, 4-11, doi:10.1097/MCP.0b013e32831da8d3.
17. Bateman, J.R.; Pavia, D.; Sheahan, N.F.; Agnew, J.E.; Clarke, S.W. Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax 1983, 38, 463-467.
18. Agnew, J.E.; Bateman, J.R.; Pavia, D.; Clarke, S.W. Radionuclide demonstration of ventilator abnormalities in mild asthma. Clin. Sci. Lond. Engl. 1984, 66, 525-531.
19. O’Riordan, T.G.; Zwang, J.; Smaldone, G.C. Mucociliary Clearance in Adult Asthma. Am. Rev. Respir. Dis. 1992, 146, 598-603, doi:10.1164/ajrccm/146.3.598.
20. Messina, M.S.; O’riordan, T.G.; Smaldone, G.C. Changes in Mucociliary Clearance during Acute Exacerbations of Asthma. Am. Rev. Respir. Dis. 1991, 143, 993-997, doi:10.1164/ajrccm/143.5_Pt_1.993.
21. Thornton, D.J.; Rousseau, K.; McGuckin, M.A. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 2008, 70, 459-486, doi:10.1146/annurev.physiol.70.113006.100702.
22. Evans, C.M.; Koo, J.S. Airway mucus: The good, the bad, the sticky. Pharmacol. Ther. 2009, 121, 332-348, doi:10.1016/j.pharmthera.2008.11.001.
23. Lang, T.; Hansson, G.C.; Samuelsson, T. Gel-forming mucins appeared early in metazoan evolution. Proc. Natl. Acad. Sci. USA 2007, 104, 16209-16214, doi:10.1073/pnas.0705984104.
24. Rose, M.C.; Voynow, J.A. Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease. Physiol. Rev. 2006, 86, 245-278, doi:10.1152/physrev.00010.2005.
25. Perez-Vilar, J.; Hill, R.L. The Structure and Assembly of Secreted Mucins. J. Biol. Chem. 1999, 274, 31751-31754, doi:10.1074/jbc.274.45.31751.
26. Raviv, U.; Giasson, S.; Kampf, N.; Gohy, J.-F.; Jérôme, R.; Klein, J. Lubrication by charged polymers. Nature 2003, 425, 163-165, doi:10.1038/nature01970.
27. Asker, N.; Axelsson, M.A.; Olofsson, S.O.; Hansson, G.C. Human MUC5AC mucin dimerizes in the rough endoplasmic reticulum, similarly to the MUC2 mucin. Biochem. J. 1998, 335, 381-387.
28. Perez-Vilar, J.; Eckhardt, A.E.; DeLuca, A.; Hill, R.L. Porcine submaxillary mucin forms disulfide-linked multimers through its amino-terminal D-domains. J. Biol. Chem. 1998, 273, 14442-14449.
29. Perez-Vilar, J.; Eckhardt, A.E.; Hill, R.L. Porcine Submaxillary Mucin Forms Disulfide-bonded Dimers between Its Carboxyl-terminal Domains. J. Biol. Chem. 1996, 271, 9845-9850, doi:10.1074/jbc.271.16.9845.
30. Sheehan, J.K.; Kirkham, S.; Howard, M.; Woodman, P.; Kutay, S.; Brazeau, C.; Buckley, J.; Thornton, D.J. Identification of Molecular Intermediates in the Assembly Pathway of the MUC5AC Mucin. J. Biol. Chem. 2004, 279, 15698-15705, doi:10.1074/jbc.M313241200.
31. Verdugo, P.; Deyrup-Olsen, I.; Aitken, M.; Villalon, M.; Johnson, D. Molecular Mechanism of Mucin Secretion: I. The Role of Intragranular Charge Shielding. J. Dent. Res. 1987, 66, 506-508, doi:10.1177/00220345870660022001.
32. Forstner, G. Signal Transduction Packaging and Secretion of Mucins. Annu. Rev. Physiol. 1995, 57, 585-605, doi:10.1146/annurev.ph.57.030195.003101.
33. Ridley, C.; Kouvatsos, N.; Raynal, B.D.; Howard, M.; Collins, R.F.; Desseyn, J.-L.; Jowitt, T.A.; Baldock, C.; Davis, C.W.; Hardingham, T.E. et al. Assembly of the Respiratory Mucin MUC5B A NEW MODEL FOR A GEL-FORMING MUCIN. J. Biol. Chem. 2014, 289, 16409-16420, doi:10.1074/jbc.M114.566679.
34. Kesimer, M.; Makhov, A.M.; Griffith, J.D.; Verdugo, P.; Sheehan, J.K. Unpacking a gel-forming mucin: A view of MUC5B organization after granular release. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2010, 298, L15-L22, doi:10.1152/ajplung.00194.2009.
35. Verdugo, P. Mucin exocytosis. Am. Rev. Respir. Dis. 1991, 144, S33-S37, doi:10.1164/ajrccm/144.3_pt_2.S33.
36. Chen, E.Y.T.; Yang, N.; Quinton, P.M.; Chin, W.-C. A new role for bicarbonate in mucus formation. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2010, 299, L542-L549, doi:10.1152/ajplung.00180.2010.
37. Audie, J.P.; Janin, A.; Porchet, N.; Copin, M.C.; Gosselin, B.; Aubert, J.P. Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J. Histochem. Cytochem. Off. J. Histochem. Soc. 1993, 41, 1479-1485.
38. Porchet, N.; Pigny, P.; Buisine, M.-P.; Debailleul, V.; Degand, P.; Laine, A.; Aubert, J.-P. Human mucin genes: Genomic organization and expression of MUC4, MUC5AC and MUC5B. Biochem. Soc. Trans. 1995, 23, 800-805, doi:10.1042/bst0230800.
39. Reid, C.J.; Gould, S.; Harris, A. Developmental Expression of Mucin Genes in the Human Respiratory Tract. Am. J. Respir. Cell Mol. Biol. 1997, 17, 592-598, doi:10.1165/ajrcmb.17.5.2798.
40. Buisine, M.-P.; Devisme, L.; Copin, M.-C.; Durand-Réville, M.; Gosselin, B.; Aubert, J.-P.; Porchet, N. Developmental Mucin Gene Expression in the Human Respiratory Tract. Am. J. Respir. Cell Mol. Biol. 1999, 20, 209-218, doi:10.1165/ajrcmb.20.2.3259.
41. Chen, Y.; Zhao, Y.H.; Kalaslavadi, T.B.; Hamati, E.; Nehrke, K.; Le, A.D.; Ann, D.K.; Wu, R. Genome-Wide Search and Identification of a Novel Gel-Forming Mucin MUC19/Muc19 in Glandular Tissues. Am. J. Respir. Cell Mol. Biol. 2004, 30, 155-165, doi:10.1165/rcmb.2003-0103OC.
42. Hovenberg, H.W.; Davies, J.R.; Herrmann, A.; Lindén, C.J.; Carlstedt, I. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj. J. 1996, 13, 839-847.
43. Wickström, C.; Davies, J.R.; Eriksen, G.V.; Veerman, E.C.; Carlstedt, I. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: Identification of glycoforms and C-terminal cleavage. Biochem. J. 1998, 334, 685-693.
44. Kirkham, S.; Sheehan, J.K.; Knight, D.; Richardson, P.S.; Thornton, D.J. Heterogeneity of airways mucus: Variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem. J. 2002, 361, 537-546, doi:10.1042/bj3610537.
45. Thornton, D.J.; Howard, M.; Khan, N.; Sheehan, J.K. Identification of Two Glycoforms of the MUC5B Mucin in Human Respiratory Mucus EVIDENCE FOR A CYSTEINE-RICH SEQUENCE REPEATED WITHIN THE MOLECULE. J. Biol. Chem. 1997, 272, 9561-9566, doi:10.1074/jbc.272.14.9561.
46. Kesimer, M.; Kirkham, S.; Pickles, R.J.; Henderson, A.G.; Alexis, N.E.; Demaria, G.; Knight, D.; Thornton, D.J.; Sheehan, J.K. Tracheobronchial air-liquid interface cell culture: A model for innate mucosal defense of the upper airways? Am. J. Physiol.-Lung Cell. Mol. Physiol. 2009, 296, L92-L100, doi:10.1152/ajplung.90388.2008.
47. Groneberg, D.A.; Eynott, P.R.; Lim, S.; Oates, T.; Wu, R.; Carlstedt, I.; Roberts, P.; McCann, B.; Nicholson, A.G.; Harrison, B.D. et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 2002, 40, 367-373.
48. Groneberg, D.A.; Eynott, P.R.; Oates, T.; Lim, S.; Wu, R.; Carlstedt, I.; Nicholson, A.G.; Chung, K.F. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir. Med. 2002, 96, 81-86, doi:10.1053/rmed.2001.1221.
49. Hovenberg, H.W.; Davies, J.R.; Carlstedt, I. Different mucins are produced by the surface epithelium and the submucosa in human trachea: Identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 1996, 318, 319-324.
50. Seibold, M.A.; Smith, R.W.; Urbanek, C.; Groshong, S.D.; Cosgrove, G.P.; Brown, K.K.; Schwarz, M.I.; Schwartz, D.A.; Reynolds, S.D. The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium. PLoS ONE 2013, 8, e58658, doi:10.1371/journal.pone.0058658.
51. Seibold, M.A.; Wise, A.L.; Speer, M.C.; Steele, M.P.; Brown, K.K.; Loyd, J.E.; Fingerlin, T.E.; Zhang, W.; Gudmundsson, G.; Groshong, S.D. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011, 364, 1503-1512, doi:10.1056/NEJMoa1013660.
52. Bonser, L.R.; Zlock, L.; Finkbeiner, W.; Erle, D.J. Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J. Clin. Investig. 2016, 126, 2367-2371, doi:10.1172/JCI84910.
53. Lachowicz-Scroggins, M.E.; Yuan, S.; Kerr, S.C.; Dunican, E.M.; Yu, M.; Carrington, S.D.; Fahy, J.V. Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. Am. J. Respir. Crit. Care Med. 2016, 194, 1296-1299, doi:10.1164/rccm.201603-0526LE.
54. Ermund, A.; Meiss, L.N.; Rodriguez-Pineiro, A.M.; Bähr, A.; Nilsson, H.E.; Trillo-Muyo, S.; Ridley, C.; Thornton, D.J.; Wine, J.J.; Hebert, H. et al. The normal trachea is cleaned by MUC5B mucin bundles from the submucosal glands coated with the MUC5AC mucin. Biochem. Biophys. Res. Commun. 2017, 492, 331-337, doi:10.1016/j.bbrc.2017.08.113.
55. Ostedgaard, L.S.; Moninger, T.O.; McMenimen, J.D.; Sawin, N.M.; Parker, C.P.; Thornell, I.M.; Powers, L.S.; Gansemer, N.D.; Bouzek, D.C.; Cook, D.P. et al. Gel-forming mucins form distinct morphologic structures in airways. Proc. Natl. Acad. Sci. USA 2017, 114, 6842-6847, doi:10.1073/pnas.1703228114.
56. Thornton, D.J.; Davies, J.R.; Kraayenbrink, M.; Richardson, P.S.; Sheehan, J.K.; Carlstedt, I. Mucus glycoproteins from ‘normal’ human tracheobronchial secretion. Biochem. J. 1990, 265, 179-186, doi:10.1042/bj2650179.
57. Sheehan, J.K.; Brazeau, C.; Kutay, S.; Pigeon, H.; Kirkham, S.; Howard, M.; Thornton, D.J. Physical characterization of the MUC5AC mucin: A highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem. J. 2000, 347, 37-44, doi:10.1042/bj3470037.
58. Raclawska, D.S.; Ttofali, F.; Fletcher, A.A.; Harper, D.N.; Bochner, B.S.; Janssen, W.J.; Evans, C.M. Mucins and Their Sugars. Critical Mediators of Hyperreactivity and Inflammation. Ann. Am. Thorac. Soc. 2016, 13 (Suppl. 1), S98-S99, doi:10.1513/AnnalsATS.201511-743MG.
59. −/− baseline secretion defect reveals source of oligomeric mucins in mouse airways. J. Physiol. 2008, 586, 1977-1992, doi:10.1113/jphysiol.2007.149310.
60. Roy, M.G.; Livraghi-Butrico, A.; Fletcher, A.A.; McElwee, M.M.; Evans, S.E.; Boerner, R.M.; Alexander, S.N.; Bellinghausen, L.K.; Song, A.S.; Petrova, Y.M. et al. Muc5b is required for airway defence. Nature 2014, 505, 412-416, doi:10.1038/nature12807.
61. Livraghi-Butrico, A.; Grubb, B.R.; Wilkinson, K.J.; Volmer, A.S.; Burns, K.A.; Evans, C.M.; O’Neal, W.K.; Boucher, R.C. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease. Mucosal Immunol. 2017, 10, 395-407, doi:10.1038/mi.2016.63.
62. Evans, C.M.; Raclawska, D.S.; Ttofali, F.; Liptzin, D.R.; Fletcher, A.A.; Harper, D.N.; McGing, M.A.; McElwee, M.M.; Williams, O.W.; Sanchez, E. et al. The polymeric mucin Muc5ac is required for allergic airway hyperreactivity. Nat. Commun. 2015, 6, doi:10.1038/ncomms7281.
63. Ehre, C.; Worthington, E.N.; Liesman, R.M.; Grubb, B.R.; Barbier, D.; O’Neal, W.K.; Sallenave, J.-M.; Pickles, R.J.; Boucher, R.C. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc. Natl. Acad. Sci. USA 2012, 109, 16528-16533, doi:10.1073/pnas.1206552109.
64. Koeppen, M.; McNamee, E.N.; Brodsky, K.S.; Aherne, C.M.; Faigle, M.; Downey, G.P.; Colgan, S.P.; Evans, C.M.; Schwartz, D.A.; Eltzschig, H.K. Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury. Mucosal Immunol. 2013, 6, 762-775, doi:10.1038/mi.2012.114.
65. Rock, J.R.; Randell, S.H.; Hogan, B.L.M. Airway basal stem cells: A perspective on their roles in epithelial homeostasis and remodeling. Dis. Models Mech. 2010, 3, 545-556, doi:10.1242/dmm.006031.
66. Curran, D.R.; Cohn, L. Advances in Mucous Cell Metaplasia. Am. J. Respir. Cell Mol. Biol. 2010, 42, 268-275, doi:10.1165/rcmb.2009-0151TR.
67. Woodruff, P.G.; Modrek, B.; Choy, D.F.; Jia, G.; Abbas, A.R.; Ellwanger, A.; Arron, J.R.; Koth, L.L.; Fahy, J.V. T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma. Am. J. Respir. Crit. Care Med. 2009, 180, 388-395, doi:10.1164/rccm.200903-0392OC.
68. Kuperman, D.A.; Lewis, C.C.; Woodruff, P.G.; Rodriguez, M.W.; Yang, Y.H.; Dolganov, G.M.; Fahy, J.V.; Erle, D.J. Dissecting asthma using focused transgenic modeling and functional genomics. J. Allergy Clin. Immunol. 2005, 116, 305-311, doi:10.1016/j.jaci.2005.03.024.
69. Woodruff, P.G.; Boushey, H.A.; Dolganov, G.M.; Barker, C.S.; Yang, Y.H.; Donnelly, S.; Ellwanger, A.; Sidhu, S.S.; Dao-Pick, T.P.; Pantoja, C. et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 2007, 104, 15858-15863, doi:10.1073/pnas.0707413104.
70. Zhen, G.; Park, S.W.; Nguyenvu, L.T.; Rodriguez, M.W.; Barbeau, R.; Paquet, A.C.; Erle, D.J. IL-13 and Epidermal Growth Factor Receptor Have Critical but Distinct Roles in Epithelial Cell Mucin Production. Am. J. Respir. Cell Mol. Biol. 2007, 36, 244-253, doi:10.1165/rcmb.2006-0180OC.
71. Solberg, O.D.; Ostrin, E.J.; Love, M.I.; Peng, J.C.; Bhakta, N.R.; Hou, L.; Nguyen, C.; Solon, M.; Nguyen, C.; Barczak, A.J. et al. Airway Epithelial miRNA Expression Is Altered in Asthma. Am. J. Respir. Crit. Care Med. 2012, 186, 965-974, doi:10.1164/rccm.201201-0027OC.
72. Lachowicz-Scroggins, M.E.; Finkbeiner, W.E.; Gordon, E.D.; Yuan, S.; Zlock, L.; Bhakta, N.R.; Woodruff, P.G.; Fahy, J.V.; Boushey, H.A. Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia. Clin. Exp. Allergy 2017, doi:10.1111/cea.13015.
73. Kuperman, D.A.; Huang, X.; Koth, L.L.; Chang, G.H.; Dolganov, G.M.; Zhu, Z.; Elias, J.A.; Sheppard, D.; Erle, D.J. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 2002, 8, 885-889, doi:10.1038/nm734.
74. Laoukili, J.; Perret, E.; Willems, T.; Minty, A.; Parthoens, E.; Houcine, O.; Coste, A.; Jorissen, M.; Marano, F.; Caput, D. et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J. Clin. Investig. 2001, 108, 1817-1824.
75. 4+ T cells and airway structural cells to type 2 inflammation. Sci. Transl. Med. 2016, 8, 359ra132, doi:10.1126/scitranslmed.aag1370.
76. Takeyama, K.; Dabbagh, K.; Lee, H.-M.; Agustí, C.; Lausier, J.A.; Ueki, I.F.; Grattan, K.M.; Nadel, J.A. Epidermal growth factor system regulates mucin production in airways. Proc. Natl. Acad. Sci. USA 1999, 96, 3081-3086, doi:10.1073/pnas.96.6.3081.
77. Cras, T.D.L.; Acciani, T.H.; Mushaben, E.M.; Kramer, E.L.; Pastura, P.A.; Hardie, W.D.; Korfhagen, T.R.; Sivaprasad, U. et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2011, 300, L414-L421, doi:10.1152/ajplung.00346.2010.
78. Takeyama, K.; Fahy, J.V.; Nadel, J.A. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am. J. Respir. Crit. Care Med. 2001, 163, 511-516, doi:10.1164/ajrccm.163.2.2001038.
79. Donoghue, L.J.; Livraghi-Butrico, A.; McFadden, K.M.; Thomas, J.M.; Chen, G.; Grubb, B.R.; O’Neal, W.K.; Boucher, R.C.; Kelada, S.N.P. Identification of trans Protein QTL for Secreted Airway Mucins in Mice and a Causal Role for Bpifb1. Genetics 2017, 207, 801-812, doi:10.1534/genetics.117.300211.
80. Aikawa, T.; Shimura, S.; Sasaki, H.; Ebina, M.; Takishima, T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992, 101, 916-921.
81. Ordoñez, C.L.; Khashayar, R.; Wong, H.H.; Ferrando, R.; Wu, R.; Hyde, D.M.; Hotchkiss, J.A.; Zhang, Y.; Novikov, A.; Dolganov, G. et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit. Care Med. 2001, 163, 517-523, doi:10.1164/ajrccm.163.2.2004039.
82. Crystal, R.G. Airway Basal Cells. The “Smoking Gun” of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2014, 190, 1355-1362, doi:10.1164/rccm.201408-1492PP.
83. Boucherat, O.; Morissette, M.C.; Provencher, S.; Bonnet, S.; Maltais, F. Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis. Am. J. Respir. Crit. Care Med. 2015, 193, 362-375, doi:10.1164/rccm.201508-1518PP.
84. Danahay, H.; Pessotti, A.D.; Coote, J.; Montgomery, B.E.; Xia, D.; Wilson, A.; Yang, H.; Wang, Z.; Bevan, L.; Thomas, C. et al. Notch2 Is Required for Inflammatory Cytokine-Driven Goblet Cell Metaplasia in the Lung. Cell Rep. 2015, 10, 239-252, doi:10.1016/j.celrep.2014.12.017.
85. Lafkas, D.; Shelton, A.; Chiu, C.; de Leon Boenig, G.; Chen, Y.; Stawicki, S.S.; Siltanen, C.; Reichelt, M.; Zhou, M.; Wu, X. et al. Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung. Nature 2015, 528, 127-131, doi:10.1038/nature15715.
86. Rajavelu, P.; Chen, G.; Xu, Y.; Kitzmiller, J.A.; Korfhagen, T.R.; Whitsett, J.A. Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation. J. Clin. Investig. 2015, 125, 2021-2031, doi:10.1172/JCI79422.
87. Chen, G.; Korfhagen, T.R.; Karp, C.L.; Impey, S.; Xu, Y.; Randell, S.H.; Kitzmiller, J.; Maeda, Y.; Haitchi, H.M.; Sridharan, A. et al. Foxa3 Induces Goblet Cell Metaplasia and Inhibits Innate Antiviral Immunity. Am. J. Respir. Crit. Care Med. 2014, 189, 301-313, doi:10.1164/rccm.201306-1181OC.
88. Park, K.-S.; Korfhagen, T.R.; Bruno, M.D.; Kitzmiller, J.A.; Wan, H.; Wert, S.E.; Khurana Hershey, G.K.; Chen, G.; Whitsett, J.A. SPDEF regulates goblet cell hyperplasia in the airway epithelium. J. Clin. Investig. 2007, 117, 978-988, doi:10.1172/JCI29176.
89. Song, J.; Heijink, I.H.; Kistemaker, L.E.M.; Reinders-Luinge, M.; Kooistra, W.; Noordhoek, J.A.; Gosens, R.; Brandsma, C.A.; Timens, W.; Hiemstra, P.S. et al. Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD. Clin. Epigenet. 2017, 9, 42, doi:10.1186/s13148-017-0341-7.
90. Song, J.; Cano-Rodriquez, D.; Winkle, M.; Gjaltema, R.A.F.; Goubert, D.; Jurkowski, T.P.; Heijink, I.H.; Rots, M.G.; Hylkema, M.N. Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2017, 312, L334-L347, doi:10.1152/ajplung.00059.2016.
91. Chen, G.; Korfhagen, T.R.; Xu, Y.; Kitzmiller, J.; Wert, S.E.; Maeda, Y.; Gregorieff, A.; Clevers, H.; Whitsett, J.A. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J. Clin. Investig. 2009, 119, 2914-2924, doi:10.1172/JCI39731.
92. Wan, H.; Kaestner, K.H.; Ang, S.-L.; Ikegami, M.; Finkelman, F.D.; Stahlman, M.T.; Fulkerson, P.C.; Rothenberg, M.E.; Whitsett, J.A. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2004, 131, 953-964, doi:10.1242/dev.00966.
93. Chen, G.; Wan, H. Luo, F.; Zhang, L.; Xu, Y.; Lewkowich, I.; Wills-Karp, M.; Whitsett, J.A. Foxa2 Programs Th2 Cell-Mediated Innate Immunity in the Developing Lung. J. Immunol. 2010, 184, 6133-6141, doi:10.4049/jimmunol.1000223.
94. Young, H.W.J.; Williams, O.W.; Chandra, D.; Bellinghausen, L.K.; Pérez, G.; Suárez, A.; Tuvim, M.J.; Roy, M.G.; Alexander, S.N.; Moghaddam, S.J. et al. Central Role of Muc5ac Expression in Mucous Metaplasia and Its Regulation by Conserved 5′ Elements. Am. J. Respir. Cell Mol. Biol. 2007, 37, 273-290, doi:10.1165/rcmb.2005-0460OC.
95. Welsh, K.G.; Rousseau, K.; Fisher, G.; Bonser, L.R.; Bradding, P.; Brightling, C.E.; Thornton, D.J.; Gaillard, E.A. MUC5AC and a glycosylated variant of MUC5B alter mucin composition in children with acute asthma. Chest 2017, doi:10.1016/j.chest.2017.07.001.
96. Sheehan, J.K.; Richardson, P.S.; Fung, D.C.; Howard, M.; Thornton, D.J. Analysis of respiratory mucus glycoproteins in asthma: A detailed study from a patient who died in status asthmaticus. Am. J. Respir. Cell Mol. Biol. 1995, 13, 748-756, doi:10.1165/ajrcmb.13.6.7576713.
97. Innes, A.L.; McGrath, K.W.; Dougherty, R.H.; McCulloch, C.E.; Woodruff, P.G.; Seibold, M.A.; Okamoto, K.S.; Ingmundson, K.J.; Solon, M.C.; Carrington, S.D. et al. The H Antigen at Epithelial Surfaces Is Associated with Susceptibility to Asthma Exacerbation. Am. J. Respir. Crit. Care Med. 2011, 183, 189-194, doi:10.1164/rccm.201003-0488OC.
98. Lopez-Vidriero, M.T.; Reid, L. Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases. Am. Rev. Respir. Dis. 1978, 117, 465-477, doi:10.1164/arrd.1978.117.3.465.
99. Innes, A.L.; Carrington, S.D.; Thornton, D.J.; Kirkham, S.; Rousseau, K.; Dougherty, R.H.; Raymond, W.W.; Caughey, G.H.; Muller, S.J.; Fahy, J.V. Ex Vivo Sputum Analysis Reveals Impairment of Protease-dependent Mucus Degradation by Plasma Proteins in Acute Asthma. Am. J. Respir. Crit. Care Med. 2009, 180, 203-210, doi:10.1164/rccm.200807-1056OC.
100. Yuan, S.; Hollinger, M.; Lachowicz-Scroggins, M.E.; Kerr, S.C.; Dunican, E.M.; Daniel, B.M.; Ghosh, S.; Erzurum, S.C.; Willard, B.; Hazen, S.L. et al. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels. Sci. Transl. Med. 2015, 7, 276ra27, doi:10.1126/scitranslmed.3010525.
101. Kesic, M.J.; Hernandez, M.; Jaspers, I. Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased Influenza A virus cleavage and replication. Respir. Res. 2012, 13, 82, doi:10.1186/1465-9921-13-82.
102. Shimura, S.; Andoh, Y.; Haraguchi, M.; Shirato, K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur. Respir. J. 1996, 9, 1395-1401.
103. Abdullah, L.H.; Evans, J.R.; Wang, T.T.; Ford, A.A.; Makhov, A.M.; Nguyen, K.; Coakley, R.D.; Griffith, J.D.; Davis, C.W.; Ballard, S.T. et al. Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways. JCI Insight 2017, 2, e89752, doi:10.1172/jci.insight.89752.
104. Tang, X.X.; Ostedgaard, L.S.; Hoegger, M.J.; Moninger, T.O.; Karp, P.H.; McMenimen, J.D.; Choudhury, B.; Varki, A.; Stoltz, D.A.; Welsh, M.J. Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J. Clin. Investig. 2016, 126, 879-891, doi:10.1172/JCI83922.
105. Shimura, S.; Sasaki, T.; Sasaki, H.; Takishima, T. Chemical properties of bronchorrhea sputum in bronchial asthma. Chest 1988, 94, 1211-1215.
106. Kerr, S.C.; Carrington, S.D.; Oscarson, S.; Gallagher, M.E.; Solon, M.; Yuan, S.; Ahn, J.N.; Dougherty, R.H.; Finkbeiner, W.E.; Peters, M.C. et al. Intelectin-1 Is a Prominent Protein Constituent of Pathologic Mucus Associated with Eosinophilic Airway Inflammation in Asthma. Am. J. Respir. Crit. Care Med. 2014, 189, 1005-1007, doi:10.1164/rccm.201312-2220LE.
107. Capri, S.; Gallus, G.; Grassi, C.; Huchon, G.J.; Irvine, S.H.; Lopez-Vidriero, M.T.; Luisetti, M.; Lungarella, G.; Marriott, C.; Marsac, J. et al. Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs. Chest 1994, 106, 1532-1537.
108. Rogers, D.F.; Barnes, P.J. Treatment of airway mucus hypersecretion. Ann. Med. 2006, 38, 116-125, doi:10.1080/07853890600585795.
109. Sadowska, A.M. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther. Adv. Respir. Dis. 2012, 6, 127-135, doi:10.1177/1753465812437563.
110. Daviskas, E.; Anderson, S.D.; Gonda, I.; Eberl, S.; Meikle, S.; Seale, J.P.; Bautovich, G. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur. Respir. J. 1996, 9, 725-732.
111. Cotgreave, I.A.; Eklund, A.; Larsson, K.; Moldéus, P.W. No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur. J. Respir. Dis. 1987, 70, 73-77.
112. Shen, Y.; Cai, W.; Lei, S.; Zhang, Z. Effect of high/low dose N-acetylcysteine on chronic obstructive pulmonary disease: A systematic review and meta-analysis. COPD 2014, 11, 351-358, doi:10.3109/15412555.2013.858315.
113. Dano, G. Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergol. 1971, 26, 181-190.
114. Gillissen, A.; Jaworska, M.; Orth, M.; Coffiner, M.; Maes, P.; App, E.M.; Cantin, A.M.; Schultze-Werninghaus, G. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir. Med. 1997, 91, 159-168.
115. Suk, J.S.; Boylan, N.J.; Trehan, K.; Tang, B.C.; Schneider, C.S.; Lin, J.-M.G.; Boyle, M.P.; Zeitlin, P.L.; Lai, S.K.; Cooper, M.J. et al. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Mol. Ther. J. Am. Soc. Gene Ther. 2011, 19, 1981-1989, doi:10.1038/mt.2011.160.
116. Rao, S.; Wilson, D.B.; Brooks, R.C.; Sproule, B.J. Acute effects of nebulization of N-acetylcysteine on pulmonary mechanics and gas exchange. Am. Rev. Respir. Dis. 1970, 102, 17-22, doi:10.1164/arrd.1970.102.1.17.
117. Fuchs, H.J.; Borowitz, D.S.; Christiansen, D.H.; Morris, E.M.; Nash, M.L.; Ramsey, B.W.; Rosenstein, B.J.; Smith, A.L.; Wohl, M.E. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl. J. Med. 1994, 331, 637-642, doi:10.1056/NEJM199409083311003.
118. Laube, B.L.; Auci, R.M.; Shields, D.E.; Christiansen, D.H.; Lucas, M.K.; Fuchs, H.J.; Rosenstein, B.J. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am. J. Respir. Crit. Care Med. 1996, 153, 752-760, doi:10.1164/ajrccm.153.2.8564129.
119. Katial, R.K.; Bernstein, D.; Prazma, C.M.; Lincourt, W.R.; Stempel, D.A. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. Allergy Asthma Proc. 2011, 32, 127-136, doi:10.2500/aap.2011.32.3426.
120. Murray, C.S.; Custovic, A.; Lowe, L.A.; Aldington, S.; Williams, M.; Beasley, R.; Woodcock, A. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma. Allergy Asthma Proc. 2010, 31, 415-421, doi:10.2500/aap.2010.31.3362.
121. Kitano, M.; Ishinaga, H.; Shimizu, T.; Takeuchi, K.; Majima, Y. Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea. Pharmacology 2011, 87, 56-62, doi:10.1159/000322837.
122. Southam, D.S.; Ellis, R.; Wattie, J.; Glass, W.; Inman, M.D. Goblet cell rebound and airway dysfunction with corticosteroid withdrawal in a mouse model of asthma. Am. J. Respir. Crit. Care Med. 2008, 178, 1115-1122, doi:10.1164/rccm.200801-084OC.
123. Riesenfeld, E.P.; Sullivan, M.J.; Thompson-Figueroa, J.A.; Haverkamp, H.C.; Lundblad, L.K.; Bates, J.H.T.; Irvin, C.G. Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir. Res. 2010, 11, 22, doi:10.1186/1465-9921-11-22.
124. Fahy, J.V.; Fleming, H.E.; Wong, H.H.; Liu, J.T.; Su, J.Q.; Reimann, J.; Fick, R.B.; Boushey, H.A. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am. J. Respir. Crit. Care Med. 1997, 155, 1828-1834, doi:10.1164/ajrccm.155.6.9196082.
125. Corren, J.; Lemanske, R.F.J.; Hanania, N.A.; Korenblat, P.E.; Parsey, M.V.; Arron, J.R.; Harris, J.M.; Scheerens, H.; Wu, L.C.; Su, Z. et al. Lebrikizumab Treatment in Adults with Asthma. N. Engl. J. Med. 2011, 365, 1088-1098, doi:10.1056/NEJMoa1106469.
126. Hanania, N.A.; Korenblat, P.; Chapman, K.R.; Bateman, E.D.; Kopecky, P.; Paggiaro, P.; Yokoyama, A.; Olsson, J.; Gray, S.; Holweg, C.T.J. et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): Replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir. Med. 2016, 4, 781-796, doi:10.1016/22132S-S600(16)30265-X.
127. Wenzel, S.; Ford, L.; Pearlman, D.; Spector, S.; Sher, L.; Skobieranda, F.; Wang, L.; Kirkesseli, S.; Rocklin, R.; Bock, B. et al. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels. N. Engl. J. Med. 2013, 368, 2455-2466, doi:10.1056/NEJMoa1304048.
128. Corren, J.; Parnes, J.R.; Wang, L.; Mo, M.; Roseti, S.L.; Griffiths, J.M.; van der Merwe, R. Tezepelumab in Adults with Uncontrolled Asthma. N. Engl. J. Med. 2017, 377, 936-946, doi:10.1056/NEJMoa1704064.
129. Rogers, D.F. Mucoactive drugs for asthma and COPD: Any place in therapy? Expert Opin. Investig. Drugs 2002, 11, 15-35, doi:10.1517/13543784.11.1.15.